Sex Differences and Arterial Stiffness Die Methode ist Alles by O'Rourke, Michael F. & Safar, Michel E.
Correspondence JACC Vol. 62, No. 3, 2013
July 16, 2013:255–9
258*Copenhagen University
Department of Biomedical Sciences
Blegdamsvej 3b
Copenhagen, 2200
Denmark
E-mail: stelar@sund.ku.dk
http://dx.doi.org/10.1016/j.jacc.2013.03.044REFERENCES
1. Larsen S, Stride N, Hey-Mogensen M, et al. Simvastatin effects on
skeletal muscle: relation to decreased mitochondrial function and glucose
intolerance. J Am Coll Cardiol 2013;61:44–53.
2. Barros MH, Johnson A, Marbois BN, et al. The Saccharomyces
cerevisiae COQ10 gene encodes a START domain protein required
for function of coenzyme Q in respiration. J Biol Chem 2005;280:
42627–35.
3. Tran UC, Clarke CF. Endogenous synthesis of coenzyme Q in
eukaryotes. Mitochondrion 2007;7 Suppl:S62–71.
4. Paiva H, Thelen KM, Van Coster R, et al. High-dose statins and
skeletal muscle metabolism in humans: a randomized, controlled trial.
Clin Pharmacol Ther 2005;78:60–8.Sex Differences and
Arterial Stiffness
Die Methode ist Alles
We are concerned about methods used by our esteemed colleagues,
Coutinho et al. (1), and question their conclusion, based on higher
characteristic impedance (Zc) and lower total arterial compliance
(TAC), that the aorta and large elastic arteries of women are stiffer
than those of men. Both calculated Zc and TAC relate volume to
pressure without scaling. The aorta of a child is small. With
growth, Zc decreases and TAC increases, but this cannot be
interpreted as lower stiffness because arteries become more, not
less, stiff with age (2). Likewise, small animals have higher Zc and
lower TAC than larger animals. Because there are systematic
differences in weight and height between male and female adult
cohorts (2), the (smaller) females will appear to have stiffer arteries
(i.e., higher Zc and lower TAC) than men if not appropriately
scaled for body size. When appropriately scaled to aortic cross-
sectional area in Table 1 of Coutinho et al. (1), Zc in males
(172  10 cm2 ¼ 1,720 dynes $ s $ cm3) and in females (211 
8.3 ¼ 1,751 dynes $ s $ cm3) are virtually identical. With the same
scaling, TAC also appears identical.
Scaling is used elsewhere in the authors’ data analysis, but not
consistently. Smaller echo dimensions in females are consistent
with smaller body size (Table 1 [1]). Height and weight are not
provided in the table, text, or online appendix.
The authors’ Table 1 (1) contains many anomalies that ought be
considered and explained. Ampliﬁcation of the pressure wave
between the central and peripheral sites is 3%, not 5%, in males,
and 3%, not zero, in females. Both values are much lower than
measured invasively (2). Mean pressure, calculated as (brachial dia-
stolic blood pressure  2 þ systolic blood pressure) O 3 (data
supplement [1]), is 93, not 97, mmHg for males and 92, not 98, mm
Hg for females. Values for left ventricular (LV) outﬂow tractdiameter must be centimeters, not millimeters (i.e., 2.3 cm male,
2.0 cm female). Taper in diameter of 55% in males (35.6/23.0) and
63% for females (32.6/20.0) over a length of <5 cm between the
LV outﬂow tract and site of aortic diameter measurement (which
we do not challenge) must create secondary ﬂow and turbulence in
the aorta (2). There is concern also on the low value of pressure
ampliﬁcation compared with those in the authors’ reference 9 (1)
and in the paper by Safar et al. (3) in the same issue of the Journal.
The authors are highly respected clinical investigators and
colleagues, and may not be aware of the aforementioned anomalies,
if their data were analyzed in an outside center without adequate
technical scrutiny. We have not been able to trace the source of the
quoted “NIHem” on the Internet. We need stress in papers such as
this, Carl Ludwig’s dictum: “Die Methode ist Alles” (2).
Differences in arterial hemodynamics between adult males and
females do exist, but can be attributed to shorter body length with
earlier return of wave reﬂection, and hence, greater aortic pressure
augmentation in females (the authors’ Table 1). Such greater
pressure augmentation accounts for impaired LV relaxation and the
higher prevalence of diastolic heart failure in females (2). In this,
we certainly agree.*Michael F. O’Rourke, DSc
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Cardiol 2013;61:12–9.ReplyWe thank Drs. O’Rourke and Safar, on behalf of all the authors, for
their interest in our paper (1). They highlight the importance of
“scaling” for aortic size, given the known inverse relationship
between aortic diameter and characteristic impedance (Zc) (2). The
multivariable models presented in our study (1) adjusted for aortic
diameter as a measure of body size and demonstrated that women
had higher Zc even after adjusting for aortic size. The augmenta-
tion index (AIx) was indeed higher in women than men in
our study, but was not associated with left ventricular diastolic
function or ventricular–arterial coupling. In our cohort of older,
predominantly hypertensive participants, increased proximal aortic
